Jasper Therapeutics, Inc. (JSPR) stock
JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$13.37−1.39 (-9.42%)
Close on Nov 12, 2026Market cap $444.88MP/E –Yield –
Jasper Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Jasper Therapeutics's enterprise value was $407.14M on Nov 11, 2026, against $1.49B a year earlier. Over the last 5 years it ranged from -$4.16M to $11.63B, with a median of $2.16B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $407.14M | -72.6% |
| 2025 | Dec 31, 2025 | $1.49B | -84.4% |
| 2024 | Dec 31, 2024 | $9.53B | +280.7% |
| 2023 | Dec 29, 2023 | $2.50B | +405.1% |
| 2022 | Dec 30, 2022 | $495.61M | -94.4% |
| 2021 | Dec 31, 2021 | $8.81B | +4167.6% |
| 2020 | Dec 31, 2020 | $206.33M | – |
See a number that looks wrong?